Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1

Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1

Vaccines are one of the greatest medical accomplishments to date, yet no fungal vaccines are currently available in humans mainly because opportunistic mycoses generally occur during immunodeficiencies necessary for vaccine protection. In previous studies, a live, attenuated Cryptococcus neoformans...

Full description

Bibliographic Details
Main Authors:	Tyler G. Normile, Maurizio Del Poeta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Immunology
Subjects:	Cryptococcus neoformans cryptococcosis sterylglucosides heat-killed vaccine reactivation immunotherapeutics
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.868523/full

Similar Items

Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection
by: Tyler G. Normile, et al.
Published: (2021-09-01)

Vaccination with Live or Heat-Killed Aspergillus fumigatus ΔsglA Conidia Fully Protects Immunocompromised Mice from Invasive Aspergillosis
by: Caroline Mota Fernandes, et al.
Published: (2022-10-01)

Animal Models of Cryptococcus neoformans in Identifying Immune Parameters Associated With Primary Infection and Reactivation of Latent Infection
by: Tyler G. Normile, et al.
Published: (2020-09-01)

Cryptococcosis: Review
by: A. Lima, et al.
Published: (2013-11-01)

Cryptococcosis: Review
by: A. Lima, et al.
Published: (2013-11-01)

Can smoking cause melanization of Cryptococcus neoformans in vivo?
by: Sabesan, G., et al.
Published: (2011-01-01)

Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015
by: Norida Vélez, et al.

First isolation of Cryptococcus gattii molecular type VGII and Cryptococcus neoformans molecular type VNI from environmental sources in the city of Belém, Pará, Brazil
by: Solange do PSE Costa, et al.
Published: (2009-07-01)

Tipificación molecular de aislamientos del complejo Cryptococcus neoformans/Cryptococcus gattii Molecular typing of the Cryptococcus neoformans/Cryptococcus gattii species complex
by: Patricia Escandón, et al.
Published: (2010-12-01)

Hipogamaglobulinemia como fator de risco para infecção por Cryptococcus neoformans: a propósito de dois casos Hypogammaglobulinemia as predisposing factor for Cryptococcus neoformans infection: regarding two cases
by: Roberto da Justa Pires Neto, et al.
Published: (2000-12-01)

The Role of Ceramide Synthases in the Pathogenicity of Cryptococcus neoformans
by: Mansa A. Munshi, et al.
Published: (2018-02-01)

Systematic review on Cryptococcus neoformans/Cryptococcus gattii species complex infections with recommendations for practice in health and care settings
by: Mireille H. van der Torre, et al.
Published: (2022-07-01)

The status of cryptococcosis in Latin America
by: Carolina Firacative, et al.
Published: (2018-04-01)

Criptococcose cutânea primária em paciente imunocompetente Primay cutaneous cryptococcosis in an immunocompetent patient
by: Nilton Nasser, et al.
Published: (2011-12-01)

Prevalência de Cryptococcus neoformans nos pombos urbanos da cidade de Porto Alegre, Rio Grande do Sul Prevalence of Cryptococcus neoformans in urban pigeons of Porto Alegre (RS), Brazil
by: Aline Reolon, et al.
Published: (2004-10-01)

Multiple cutaneous swellings in an immunocompetent host: cryptococcosis overlooked
by: Kranthi Kosaraju, et al.

Disseminated and cutaneous cryptococcosis by C. neoformans VNI in an immunocompetent patient
by: Fernanda Cristina A Maranhão, et al.
Published: (2020-05-01)

Suscetibilidade a antifúngicos de variedades de Cryptococcus neoformans isoladas de pacientes em hospital universitário Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital
by: Paulo Roberto da Silva, et al.
Published: (2008-04-01)

Adaptive immunology of Cryptococcus neoformans infections—an update
by: Junsong Chen, et al.
Published: (2023-05-01)

Non-Neoformans Pulmonary Cryptococcosis Due to Cryptococcus Laurentii in a Positive SARS-COV-2 Patient
by: Priscilla Adelina Duran Luciano
Published: (2023-02-01)

Cryptococcosis in Atlántico, Colombia: an approximation of the prevalence of this mycosis and the distribution of the etiological agent in the environment
by: María Clara Noguera, et al.
Published: (2015-10-01)

Adrenocortical insufficiency caused by Cryptococcus neoformans: a case report and literature review
by: LIU Hongwei, et al.
Published: (2023-05-01)

Allicin shows antifungal efficacy against Cryptococcus neoformans by blocking the fungal cell membrane
by: Zhun Li, et al.
Published: (2022-11-01)

Disseminated cryptococcosis in Crohn’s disease: a case report
by: Natthakit Chavapradit, et al.
Published: (2018-12-01)

Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System
by: Mohamed F. Hamed, et al.
Published: (2023-04-01)

A case of orbital cryptococcosis
by: Elahhe Rebecca Afkhamnejad, et al.
Published: (2023-06-01)

Cryptococcosis in Colombian children and literature review
by: Jairo Lizarazo, et al.
Published: (2014-09-01)

Organizing pneumonia secondary to pulmonary cryptococcosis in immunocompromised patient
by: Zentaro Saito, et al.
Published: (2024-01-01)

Molecular characterization of Cryptococcus neoformans isolates from HIV patients, Guayaquil, Ecuador
by: Sunny Sánchez, et al.
Published: (2017-09-01)

Laryngeal cryptococcosis; a condition reported in renal transplant recipients and other immunosuppressed patients
by: Alfonso J. Rodriguez-Morales, et al.
Published: (2017-04-01)

Cryptococcus neoformans Strains and Infection in Apparently Immunocompetent Patients, China
by: Jianghan Chen, et al.
Published: (2008-05-01)

Faster <i>Cryptococcus</i> Melanization Increases Virulence in Experimental and Human Cryptococcosis
by: Herdson Renney de Sousa, et al.
Published: (2022-04-01)

Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil)
by: Liline Maria Soares Martins, et al.
Published: (2011-09-01)

Sterylglucosides in Fungi
by: Nivea Pereira de Sa, et al.
Published: (2022-10-01)

<italic toggle="yes">Cryptococcus neoformans</italic> Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model
by: Ana Caroline Colombo, et al.
Published: (2019-04-01)

Cryptococcosis by Cryptococcus neoformans/Cryptococcus gattii Species Complexes in non-HIV-Infected Patients in Southeastern Brazil
by: Erika Nascimento, et al.
Published: (2021-09-01)

Development of a Real-Time PCR Assay to Identify and Distinguish between <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> Species Complexes
by: Enoch Tay, et al.
Published: (2022-04-01)

Cryptococcus neoformans meningitis in a Non-HIV infected, nonorgan transplant, immunocompromised individual
by: Sandhya Manorenj, et al.
Published: (2018-01-01)

Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan
by: Chang-Hua Chen, et al.
Published: (2015-08-01)

First case of feline cryptococcosis in Hong Kong, caused by Cryptococcus neoformans
by: Angel Almendros, et al.
Published: (2020-09-01)